We found that serum levels of eotaxin, IP‐10, CEA, CYFRA21‐1, and SCC could differentiate ESCC patients from healthy controls, with AUCs of 0.588, 0.590, 0.619, 0.626, and 0.589, respectively. This evidence concerns the gene CEACAM5 and esophageal squamous cell carcinoma.